| Wissenschaftl. Titel | A Randomized, Double-blind, Placebo-controlled Phase II Multi-center Study of Intravenous MBG453 Added to Hypomethylating Agents in Adult Subjects With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS) as Per IPSS-R Criteria |
| Erkrankung |
Haema:
MDS:
Alle Linien
|
| Kurzprotokoll | Kurzprotokoll |
| Links | Weiterführende Informationen (B) Weiterführende Informationen (NIH) Weiterführende Informationen (EudraCT) |
erstellt 24.09.2020 Data entry I CCP
geändert 11.07.2023 Data entry II CCP